|
MAP2K4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.176000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.705000E-01 |
| Normal-vs-Stage2 |
4.952600E-01 |
| Normal-vs-Stage3 |
2.138200E-02 |
| Normal-vs-Stage4 |
3.011700E-04 |
| Stage1-vs-Stage2 |
9.181400E-01 |
| Stage1-vs-Stage3 |
7.237500E-02 |
| Stage1-vs-Stage4 |
7.582700E-04 |
| Stage2-vs-Stage3 |
1.809550E-01 |
| Stage2-vs-Stage4 |
1.565600E-02 |
| Stage3-vs-Stage4 |
1.494450E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.151620E-01 |
| Normal-vs-AfricanAmerican |
9.265600E-01 |
| Normal-vs-Asian |
9.132000E-02 |
| Caucasian-vs-AfricanAmerican |
3.166800E-01 |
| Caucasian-vs-Asian |
6.925000E-01 |
| AfricanAmerican-vs-Asian |
2.412600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.390400E-02 |
| Normal-vs-Female |
1.097390E-01 |
| Male-vs-Female |
3.269600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.998400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.087500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.759900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.015640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.468100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.308200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.767000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.261600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.875200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.547200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.835500E-02 |
| Classical-VS-Follicular |
3.312100E-02 |
| Classical-VS-Other |
1.797450E-01 |
| Classical-VS-Normal |
4.822400E-01 |
| Tall-VS-Follicular |
7.520200E-01 |
| Tall-VS-Other |
6.263600E-01 |
| Tall-VS-Normal |
2.819900E-02 |
| Follicular-VS-Other |
5.628800E-01 |
| Follicular-VS-Normal |
3.736400E-02 |
| Other-VS-Normal |
7.588100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.041600E-02 |
| Normal-vs-N1 |
1.188040E-02 |
| N0-vs-N1 |
2.473000E-01 |
|
|
